- 2023 - 2028 未治療転移性前立腺癌に対する内分泌化学免疫療法のプレシジョンメディシンの実現
- 2023 - 2026 NOIR-SSを用いた淡明細胞型腎癌におけるctDNAの定量と背景因子の解明
- 2021 - 2026 Fluorescent Substrates for Cancer Detection Using Clinical Specimens and Animal Models Aiming for Negative Margin of Prostate Cancer Surgery
- 2021 - 2024 尿路上皮における遺伝子変異の蓄積と癌化のメカニズムの解明
- 2021 - 2024 Tailor-made immunotherapy strategy for urothelial cancer using immunogram
- 2020 - 2023 VHL病に伴う腎細胞癌のクローン進展の解明と治療戦略の基盤の確立に関する研究
- 2017 - 2021 Functional analysis of soluble B7-H3
- 2016 - 2020 Analysis of B7-H4 function in urological cancer and development of the new therapy of immunity
- 2016 - 2019 Development of cancer immunotherapy targeting mutation-derived neoantigens
- 2015 - 2019 Analysis of intra-tumor immune response toward development of autologous gamma-delta T-cell transfer therapy in patients with advanced urothelial carcinoma
- 2014 - 2017 Role of the chromatin regulating genes in the progression of renal cell carcinoma
- 2013 - 2016 Identification of unique antigens by next generation sequencing and development of individualized cancer immunotherapy in clear cell renal cell carcinoma
- 2005 - 2007 N-cadherin expression is associated with bladder cancer progression and poor prognosis
- 2004 - 2007 Research for appropriate use of interferon for renal cell carcinoma
- 2004 - 2006 Roles of Hormonal pathways in cell proliferation and hyperplasia in the human prostate
- 2003 - 2005 Clinical trial of the tailor-made medication for the treatment of prostate cancer by estramustine phosphate sodium.
- 2001 - 2002 腎細胞癌発生におけるVHL遺伝子の分子生物学的役割・関与の解明に関する研究:ユビキチン化の新規標的蛋白質の同定
Show all